270 related articles for article (PubMed ID: 7799243)
1. Anxiety or depression during withdrawal of hypnotic treatments.
Lader M
J Psychosom Res; 1994; 38 Suppl 1():113-23; discussion 118-23. PubMed ID: 7799243
[TBL] [Abstract][Full Text] [Related]
2. Rebound insomnia and newer hypnotics.
Lader M
Psychopharmacology (Berl); 1992; 108(3):248-55. PubMed ID: 1523276
[TBL] [Abstract][Full Text] [Related]
3. Hypnotic discontinuation in chronic insomnia: impact of psychological distress, readiness to change, and self-efficacy.
Belleville G; Morin CM
Health Psychol; 2008 Mar; 27(2):239-48. PubMed ID: 18377143
[TBL] [Abstract][Full Text] [Related]
4. Hypnotic Discontinuation in Chronic Insomnia.
Hintze JP; Edinger JD
Sleep Med Clin; 2020 Jun; 15(2):147-154. PubMed ID: 32386690
[TBL] [Abstract][Full Text] [Related]
5. Hypnotic Discontinuation in Chronic Insomnia.
Hintze JP; Edinger JD
Sleep Med Clin; 2018 Jun; 13(2):263-270. PubMed ID: 29759276
[TBL] [Abstract][Full Text] [Related]
6. Hypnotic drugs for 1984.
Oswald I
Psychopharmacology Suppl; 1984; 1():84-90. PubMed ID: 6147844
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological treatment of insomnia.
Maczaj M
Drugs; 1993 Jan; 45(1):44-55. PubMed ID: 7680984
[TBL] [Abstract][Full Text] [Related]
8. Rational use of anxiolytic/sedative drugs.
Lader M; Petursson H
Drugs; 1983 May; 25(5):514-28. PubMed ID: 6134609
[TBL] [Abstract][Full Text] [Related]
9. Main neuroendocrine features and therapy in primary sleep troubles.
Amihăesei IC; Mungiu OC
Rev Med Chir Soc Med Nat Iasi; 2012; 116(3):862-6. PubMed ID: 23272543
[TBL] [Abstract][Full Text] [Related]
10. The use of short- and long-acting hypnotics in clinical medicine.
Nicholson AN
Br J Clin Pharmacol; 1981; 11 Suppl 1(Suppl 1):61S-69S. PubMed ID: 6133538
[TBL] [Abstract][Full Text] [Related]
11. [Benzodiazepines and sleep].
Ansseau M
Acta Psychiatr Belg; 1985; 85(4):522-32. PubMed ID: 2865871
[TBL] [Abstract][Full Text] [Related]
12. Relaxation to assist sleep medication withdrawal.
Lichstein KL; Peterson BA; Riedel BW; Means MK; Epperson MT; Aguillard RN
Behav Modif; 1999 Jul; 23(3):379-402. PubMed ID: 10467890
[TBL] [Abstract][Full Text] [Related]
13. Rebound insomnia and rebound anxiety: a review.
Kales A; Soldatos CR; Bixler EO; Kales JD
Pharmacology; 1983; 26(3):121-37. PubMed ID: 6132413
[TBL] [Abstract][Full Text] [Related]
14. Review: Adjunctive pharmacologic approaches for benzodiazepine tapers.
Welsh JW; Tretyak V; McHugh RK; Weiss RD; Bogunovic O
Drug Alcohol Depend; 2018 Aug; 189():96-107. PubMed ID: 29906718
[TBL] [Abstract][Full Text] [Related]
15. Quality of life in older adults receiving medications for anxiety, depression, or insomnia: findings from a community-based study.
Stein MB; Barrett-Connor E
Am J Geriatr Psychiatry; 2002; 10(5):568-74. PubMed ID: 12213691
[TBL] [Abstract][Full Text] [Related]
16. Rebound insomnia and hypnotic self administration.
Roehrs T; Merlotti L; Zorick F; Roth T
Psychopharmacology (Berl); 1992; 107(4):480-4. PubMed ID: 1603890
[TBL] [Abstract][Full Text] [Related]
17. [Recommendations for the diagnosis and therapy of insomnia. German Society of Sleep Research and Sleep Medicine DGSM].
Clarenbach P; Steinberg R; Weess HG; Berger M
Nervenarzt; 1995 Oct; 66(10):723-9. PubMed ID: 7501087
[TBL] [Abstract][Full Text] [Related]
18. Sleep studies and rebound insomnia: methodological problems, laboratory findings, and clinical implications.
Lader M; Lawson C
Clin Neuropharmacol; 1987 Aug; 10(4):291-312. PubMed ID: 2902919
[No Abstract] [Full Text] [Related]
19. Rebound insomnia: its determinants and significance.
Roehrs T; Vogel G; Roth T
Am J Med; 1990 Mar; 88(3A):39S-42S. PubMed ID: 1968719
[TBL] [Abstract][Full Text] [Related]
20. [Which antipsychotic drugs are proper for HIV patients?].
Holm S; Perro C
MMW Fortschr Med; 2010 Apr; 152(17):36-8. PubMed ID: 20509258
[No Abstract] [Full Text] [Related]
[Next] [New Search]
